Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients

Area of Science:

• Immunology
• Cell Biology
• Systemic Diseases

Background:

• Sarcoidosis is a systemic disease characterized by noncaseating granulomas.
• Monocytes, immune cells, exist in subpopulations including CD14++ CD16- and CD14+ CD16+.
• Expansion of CD14+ CD16+ monocytes is observed in certain pathological conditions.

Purpose of the Study:

• To investigate the immunophenotype of blood monocytes in sarcoidosis patients.
• To determine if CD14+ CD16+ monocyte levels differ between sarcoidosis patients and healthy controls.
• To explore the correlation between CD14+ CD16+ monocytes, serum ACE levels, and purinergic receptor expression in sarcoidosis.

Main Methods:

• Two-color immunofluorescence flow cytometry was used to analyze blood monocyte immunophenotypes.
• Monocyte subpopulations (CD14++ CD16- and CD14+ CD16+) were quantified.
• Serum Angiotensin-Converting Enzyme (ACE) levels and purinergic receptor expression (via LDH release) were assessed.

Main Results:

• The percentage of CD14+ CD16+ monocytes was significantly higher in sarcoidosis patients (11.8% +/- 4.9%) compared to healthy controls (5.8% +/- 2.8%).
• A significant positive correlation was observed between serum ACE levels and the percentage of CD14+ CD16+ monocytes.
• No correlation was found between CD14+ CD16+ monocyte percentage and purinergic receptor expression.

Conclusions:

• Elevated levels of CD14+ CD16+ monocytes are characteristic of sarcoidosis.
• CD14+ CD16+ monocytes may serve as a sensitive biomarker for assessing sarcoidosis disease activity.
• Further research is warranted to elucidate the precise role of these monocytes in sarcoidosis pathogenesis.